A randomised trial of a Carer End of Life Planning Intervention (CELPI) in people dying with dementia

对痴呆症患者进行护理者临终计划干预 (CELPI) 的随机试验

• 批准号: nhmrc : 2006061
• 金额: $ 148.62万
• 依托单位国家: 澳大利亚
• 项目类别: Targeted Call for Research
• 财政年份: 2021
• 资助国家: 澳大利亚
• 起止时间: 2021-01-01 至 2025-12-31
• 项目状态: 未结题
• 来源: https://researchdata.edu.au/a-randomised-trial-dying-dementia/1792572
• 关键词: randomised; trial; Carer; End; Life

Dementia is the second highest cause of death in Australia. Although palliative care helps individuals avoid suffering and futile interventions at the end of life, only 6% of people that die of dementia receive such care. Many older people with dementia attend an ED in their final year of life. In CELPI we will trial using that opportunity of an ED visit as the trigger to implement a triad of carer education, access to palliative care and a formal planning process for participants.

痴呆症是澳大利亚第二大死亡原因。虽然姑息治疗可以帮助人们在生命的最后阶段避免痛苦和徒劳的干预，但只有6%的痴呆症患者接受了这种治疗。许多老年痴呆症患者在生命的最后一年参加艾德。在CELPI中，我们将尝试利用艾德访问的机会作为触发器，为参与者实施三位一体的护理教育，获得姑息治疗和正式的规划过程。